Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 10:45 PM
Ignite Modification Date:
2025-12-26 @ 10:45 PM
NCT ID:
NCT03512912
Eligibility Criteria:
Inclusion Criteria:
* intermittent claudication due to peripheral arterial disease
* ankle brachial index \</=0.9
* occlusion or stenosis of the superficial femoral artery
Exclusion Criteria:
* rest pain or peripheral arterial lesions
* contraindications for supervised walking therapy
* non-vascular conditions that limit patients´ walking ability
* patients that have already received supervised walking therapy
* occlusion of the deep femoral artery
* occlusion or high-grade stenoses of the iliac arteries
* stroke in the last 12 months
* premenopausal women
* diabetes mellitus, dialysis, sclerodermia and other conditions that impair leg perfusion
* active cilostazol therapy or alprostadil-infusion in the last 3 months
* pacemaker, defibrillator systems, life vest
* visible muscle contraction is not achieved without pain
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03512912
Study Brief:
Protocol Section:
NCT03512912